Here are the most exciting drugs in the pipeline right now.
Monoclonal antibody for autoimmune and neurodegenerative disorders.
A new report from OptumRx reveals the top 4 drugs in development for the second quarter of 2019.
Major blockbuster drugs slated for launch in 2019 are expected to have a significant impact on treating certain cancers, diabetes, peanut allergies, and other conditions.
In the past week, the migraine prevention drug market has suddenly heated up, with 2 new approvals by FDA.